Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
2022 · Nature Communications · 112 citations
https://doi.org/10.1038/s41467-022-30615-x
K
Katelyn Singh
Yale University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
338
Citations
7
h-index
7
i10-index
Katelyn Singh is an academic researcher from Yale University. The author has contributed to research in topics: Dermatology and Skin Diseases & Urticaria and Related Conditions & Autoimmune Bullous Skin Diseases. The author has an h-index of 7, co-authored 15 publications.
ORCID: 0000-0002-0120-4238Papers by this author
worksTreatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
2020 · JAAD Case Reports · 29 citations
https://doi.org/10.1016/j.jdcr.2019.11.016
A case of eosinophilic dermatosis of hematologic malignancy with tissue-based Th2 cytokine profiling
2022 · JAAD Case Reports · 4 citations
https://doi.org/10.1016/j.jdcr.2022.09.020
Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis
2023 · British Journal of Dermatology · 2 citations
https://doi.org/10.1093/bjd/ljad389
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat